National Peroxide Limited has scheduled its sixth annual general meeting for September 29, 2026. The meeting will be held at 11:00 am through video conferencing or other audio-visual means to transact the business as set out in the notice dated August 12, 2026.

The Board of Directors previously approved a final dividend of ₹7.00 per equity share for the financial year ended March 31, 2026, during its meeting on April 30, 2026. This dividend is subject to approval by shareholders at the upcoming AGM.

Dividend and Record Date Details

The recommended dividend represents a payout ratio of 70% on the face value of ₹10 per equity share. Shareholders on record as of September 22, 2026, will be eligible for the dividend if declared by members at the meeting.

The register of members and share transfer books will remain closed from September 23, 2026, to September 29, 2026, inclusive. This closure facilitates the determination of shareholders eligible for the dividend and participation in the annual general meeting.

Meeting Logistics and Digital Access

National Peroxide Limited will conduct the AGM entirely through remote facilities in compliance with Ministry of Corporate Affairs circulars. The venue of the AGM shall be deemed to be the Registered Office of the Company. Shareholders can participate via video conferencing or other audio-visual means. The company has provided remote e-voting facilities as well as e-voting during the meeting for all resolutions set out in the notice.

Shareholders participating through these digital channels will be counted for quorum purposes under Section 103 of the Companies Act, 2013. The annual report for FY26 and the AGM notice are available electronically on the company’s website at https://naperol.com/service/annual-report/ . Physical copies are available upon request via email to investorrelations@naperol.com .

Compliance and Shareholder Updates

Pursuant to Regulation 36(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company has sent letters with web-links to the Annual Report for FY25-26 to members who have not registered their email addresses. The cut-off date for this communication was August 28, 2026.

The company also reminds physical shareholders to update their KYC details pursuant to Master Circular No. HO/38/13/(4)2026-MIRSD-POD/I/4298/2026 dated February 06, 2026. This includes recording PAN, address, mobile number, bank account details, specimen signature, and nomination choices. Shareholders are encouraged to dematerialise physical securities and register email IDs to avail online services.

National Peroxide Limited company name approved its unaudited financial results for the quarter ended June 30, 2026 (Q1FY27), alongside a significant downward revision of its audited FY26 net profit. The company reported a Q1FY27 net profit of ₹660.89 lakh on revenue from operations of ₹9,606.77 lakh. Simultaneously, the Board retrospectively restated FY26 profits from ₹1,103.71 lakh to ₹582.42 lakh after discovering an accounting error that understated raw material costs by ₹694.63 lakh due to incorrect ERP configuration for natural gas invoices.

The restatement was executed pursuant to Indian Accounting Standard (Ind AS) 8 – Accounting Policies, Changes in Accounting Estimates and Errors. M/s. Kalyaniwalla & Mistry LLP, the statutory auditors, issued a revised audit report with an unmodified opinion but included an Emphasis of Matter paragraph highlighting the correction. The Audit Committee reviewed and recommended the revised results on August 11, 2026, followed by Board approval on August 12, 2026. In accordance with Regulation 33(3)(d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company confirmed the issuance of the revised audit report.

For Q1FY27, revenue rose to ₹9,606.77 lakh from ₹8,568.29 lakh in the corresponding quarter of FY26. Total income stood at ₹9,819.38 lakh against total expenses of ₹8,936.15 lakh. Profit before tax was ₹883.23 lakh, resulting in a profit after tax of ₹660.89 lakh. Earnings per share (EPS) for the quarter were ₹11.50, compared to ₹16.06 in Q4FY26 and ₹1.55 in Q1FY26. The company continues to operate in a single segment focused on hydrogen peroxide manufacturing.

Financial Performance Overview

The Board reaffirmed its earlier recommendation of a final dividend of 70%, amounting to ₹7 per equity share of ₹10 each for FY26, subject to shareholder approval at the Annual General Meeting (AGM). However, citing the restated profits, the Board decided not to pursue the proposal for payment of commission to Non-Executive Directors.

Corporate Actions and Auditor Reappointment

The 6th AGM is scheduled for September 29, 2026, via video conference. The register of members will remain closed from September 23, 2026, to September 29, 2026, with the record date fixed at September 22, 2026. Based on the Audit Committee’s recommendation, the Board approved the reappointment of M/s. Kalyaniwalla & Mistry LLP as statutory auditors for a second term of five consecutive years, spanning from the conclusion of the 6th AGM to the 11th AGM, covering financial years up to March 31, 2031. This reappointment is disclosed under Regulation 30 of the Listing Regulations read with the SEBI Master Circular dated January 30, 2026.

What the Numbers Show

The restatement reveals a material correction in cost accounting where natural gas expenses were previously underreported. While revenue figures remained unchanged, the adjustment increased total expenses by ₹694.63 lakh, directly reducing pre-tax profits. Despite this correction, the company maintained profitability in FY26. Strong cash generation from operations, amounting to ₹3,423.99 lakh in FY26, underscores robust underlying operational efficiency, even as working capital management saw changes in trade payables due to the correction.